“Today we know that the risk of heart attack and stroke may occur early in treatment, even in the first weeks … “There is no period of use shown to be without risk,” says Judy Racoosin, M.D., M.P.H., deputy director of FDA’s Division of Anesthesia, Analgesia, and Addiction Products.”